1
2
Bos, JM, Natsch, S, Bemt, Patricia, Pot, JLW, Nagtegaal, JE, Wieringa, A, van der Wilt, GJ, Smet, P, Kramers, C
Veröffentlicht in: Bos , JM , Natsch , S , Bemt , P , Pot , JLW , Nagtegaal , JE , Wieringa , A , van der Wilt , GJ , Smet , P & Kramers , C 2017 , ' A multifaceted intervention to reduce guideline non-adherence among prescribing physicians in Dutch hospitals ' , International Journal of Clinical Pharmacy , vol. 39 , no. 6 , pp. 1211-1219 . https://doi.org/10.1007/s11096-017-0553-0;
2017
Veröffentlicht in: Bos , JM , Natsch , S , Bemt , P , Pot , JLW , Nagtegaal , JE , Wieringa , A , van der Wilt , GJ , Smet , P & Kramers , C 2017 , ' A multifaceted intervention to reduce guideline non-adherence among prescribing physicians in Dutch hospitals ' , International Journal of Clinical Pharmacy , vol. 39 , no. 6 , pp. 1211-1219 . https://doi.org/10.1007/s11096-017-0553-0;
2017
3
4
Simoons, ML, Seldenrijk, A, Mulder, H, Birkenhager, T.K., Groothedde-Kuyvenhoven, M, Kok, R, Kramers, C, Verbeeck, W, Westra, M, Roon, E, Bakker, R, Ruhe, H
Veröffentlicht in: Simoons , ML , Seldenrijk , A , Mulder , H , Birkenhager , T K , Groothedde-Kuyvenhoven , M , Kok , R , Kramers , C , Verbeeck , W , Westra , M , Roon , E , Bakker , R & Ruhe , H 2018 , ' Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring ' , Drug Safety , vol. 41 , no. 7 , pp. 655-664 . https://doi.org/10.1007/s40264-018-0649-z;
2018
Veröffentlicht in: Simoons , ML , Seldenrijk , A , Mulder , H , Birkenhager , T K , Groothedde-Kuyvenhoven , M , Kok , R , Kramers , C , Verbeeck , W , Westra , M , Roon , E , Bakker , R & Ruhe , H 2018 , ' Limited Evidence for Risk Factors for Proarrhythmia and Sudden Cardiac Death in Patients Using Antidepressants: Dutch Consensus on ECG Monitoring ' , Drug Safety , vol. 41 , no. 7 , pp. 655-664 . https://doi.org/10.1007/s40264-018-0649-z;
2018
5
6
van Oort, S., Rutters, F., Warle-van Herwaarden, M. F., Schram, M. T., Stehouwer, C. D., Tack, C. J., Abbink, E. J., Wolffenbuttel, B. H., van der Klauw, M. M., DeVries, J. H., Siegelaar, S. E., Sijbrands, E. J., Ozcan, B., de Valk, H. W., Silvius, B., Schroijen, M. A., Jazet, I. M., van Ballegooijen, A. J., Beulens, J. W. J., Elders, P. J., Kramers, C.
Veröffentlicht in: van Oort , S , Rutters , F , Warle-van Herwaarden , M F , Schram , M T , Stehouwer , C D , Tack , C J , Abbink , E J , Wolffenbuttel , B H , van der Klauw , M M , DeVries , J H , Siegelaar , S E , Sijbrands , E J , Ozcan , B , de Valk , H W , Silvius , B , Schroijen , M A , Jazet , I M , van Ballegooijen , A J , Beulens , J W J , Elders , P J & Kramers , C 2021 , ' Characteristics associated with polypharmacy in people with type 2 diabetes : the Dutch Diabetes Pearl cohort ' , Diabetic Medicine , vol. 38 , no. 4 , 14406 . https://doi.org/10.1111/dme.14406;
2021
Veröffentlicht in: van Oort , S , Rutters , F , Warle-van Herwaarden , M F , Schram , M T , Stehouwer , C D , Tack , C J , Abbink , E J , Wolffenbuttel , B H , van der Klauw , M M , DeVries , J H , Siegelaar , S E , Sijbrands , E J , Ozcan , B , de Valk , H W , Silvius , B , Schroijen , M A , Jazet , I M , van Ballegooijen , A J , Beulens , J W J , Elders , P J & Kramers , C 2021 , ' Characteristics associated with polypharmacy in people with type 2 diabetes : the Dutch Diabetes Pearl cohort ' , Diabetic Medicine , vol. 38 , no. 4 , 14406 . https://doi.org/10.1111/dme.14406;
2021
7
van Oort, S., Rutters, F., Warlé‐van Herwaarden, M. F., Schram, M. T., Stehouwer, C. D., Tack, C. J., Abbink, E. J., Wolffenbuttel, B. H., van der Klauw, M. M., DeVries, J. H., Siegelaar, S. E., Sijbrands, E. J., Özcan, B., de Valk, H. W., Silvius, B., Schroijen, M. A., Jazet, I. M., van Ballegooijen, A. J., Beulens, J. W. J., Elders, P. J., Kramers, C.
Veröffentlicht in: Diabetic Medicine ; volume 38, issue 4 ; ISSN 0742-3071 1464-5491;
2020
Veröffentlicht in: Diabetic Medicine ; volume 38, issue 4 ; ISSN 0742-3071 1464-5491;
2020